Making sense of complex drug testing with 3D lab models and virtual screens
Learning How to Give Casual Explanations for Large Scale Virtual and Morphological Pharmacology
This project builds computer and statistical tools to find real drug effects from large 3D lab models and virtual screening so new treatments work better for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11187057 on NIH RePORTER |
What this research studies
Researchers are creating new causal inference methods to pick out cause-and-effect signals from complex biological models such as 3D organoids and high-content microscopy. They will combine large-scale image-based profiling, virtual screening data, and advanced statistics to reduce bias and highlight the changes that matter for how drugs work. The team plans to validate these methods on cell- and organoid-based systems and large virtual compound libraries. Over time this approach aims to improve which drug leads move forward toward human testing.
Who could benefit from this research
Good fit: This grant funds lab and computational development rather than a treatment trial, though patients who donate tissue for organoid banks or join related translational studies could potentially participate.
Not a fit: Patients seeking immediate therapeutic benefit are unlikely to gain direct benefit now because the project focuses on methods development, not delivering treatments.
Why it matters
Potential benefit: If successful, this work could make preclinical testing more reliable so fewer promising drugs fail in later human trials and effective treatments reach patients sooner.
How similar studies have performed: Previous work shows organoids and image-based profiling can sometimes predict drug responses, but applying large-scale causal statistics to link morphology and virtual screening is relatively new.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: O'meara, Matthew J — University of Michigan at Ann Arbor
- Study coordinator: O'meara, Matthew J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.